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We have demonstrated the synthesis of a 74,000-dalton protein (74K protein) in 
African green monkey kidney cells infected with simian virus (SV)40. The 74K 
protein was detected late during the lytic cycle. Its synthesis was inhibited by 
arabinosyl cytosine as was the synthesis of the capsid proteins. Monospecific 
antibodies raised against VP1 and VP3 precipitated the structural proteins and the 
74K protein. The 74K protein was not found in purified virions. Tryptic peptide 
analysis demonstrated that the 74K protein shares rnethionine- and serine-contain- 
ing peptides with VPl  and VP3 and thus is structurally related to the capsid 
proteins. 
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Simian virus (SV)40 productive infection is divided into early and late stages 
separated by the onset of viral DNA replication 10-12 hr after infection. The viral 
capsid proteins VPI, VP2, and VP3 are virus-encoded polypeptides synthesized in 
the late phase of SV40 replication. The proteins are destined to be incorporated into 
progeny virions [ 13. After viral DNA replication, the late region of the SV40 genome 
is transcribed into stable mRNAs of 16s and 19s. The major 16s mRNA coding for 
virion structural protein VPl consists of a leader segment transcribed clockwise from 
the L-strand between map coordinates 0.72 and 0.76 and a body segment from the 
region between map positions 0.94 and 0.17 [2-71. Late 19s mRNAs that are believed 
to be translated into virion polypeptides VP2 and VP3 [8] consist of a body segment 
that is homologous to the DNA between map positions 0.765 and 0.17 spliced to 
a variety of leader segments derived from the region between map positions 0.67 
and 0.76 [7-lo]. By tryptic peptide analysis and by in vitro translation studies it has 
been shown that VP2 and VP3 are unrelated t o  VP1 but closely related to each other 
In this study we demonstrate the synthesis of a 74,000-dalton protein in African 
green monkey kidney (AGMK) cells after lytic infection with SV40. We show that 
the 74K protein is a virus-encoded protein synthesized in infected permissive cells 
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after the onset of viral DNA-replication. Tryptic peptide mapping reveals that the 
74K protein shares methionine- and serine-containing peptides with VPl and VP3. 
The 74K protein thus seems to be constructed of VP1 and part of VP3. 
MATERIALS AND METHODS 
Cells and Viruses 
Primary African green monkey kidney cells (AGMK) were grown in Eagle 
minimum essential medium (MEM) supplemented with 5% fetal calf serum [ 151. CV- 
1 cells were grown in Dulbecco modified Eagle medium (DMEM) containing 10% 
newborn calf serum. The SV40 strain 777 propagated in AGMK cells was used in 
most experiments [16]. The virus stocks were grown at low multiplicity (0.01 tissue 
culture infective dose (TCID)50/cell) from single plaques. 
Radioactive Labeling and Purification of Virus 
CV-1 cells were incubated with SV40 at a multiplicity of infection of 0.05 
TCID~o/cells. After 2-hr adsorption the virus suspension was replaced by fresh 
medium. Labeling was carried out by addition of 100 pCi [35S] methionine (600-800 
Ci/mmole) per 1.5 x lo7 cells. Seven days after infection the cells were harvested. 
Extraction and purification of SV40 was done exactly as described [ 171. 
Infection and Labeling of Cells 
Confluent cultures of primary AGMK cells and CV-1 cells were infected with 
SV40 at multiplicities of 10-50 TCID50/cell and incubated at 37°C. Control cells 
were incubated with lysates from uninfected cells. For inhibition of viral DNA 
synthesis, 25 pg cytosine arabinoside (Ara-C) per ml medium was present after 
infection and during labeling of the cells. After the indicated times cultures were 
labeled for 12 hr with 300-500 pCi [35S] methionine or with 600 pCi [3H] serine in 3 
ml methionine- or serine-free DMEM per 5 x f06 cells. 
Preparation of Cell Extracts 
At the end of the labeling periods the monolayers were washed three times with 
TRIS-deficient buffer (TD: 25 mM TRIS-HCl, pH 7.4, 5 mM KCl). The cells were 
then harvested in TD-buffer containing 0.02 % ethylenediamine tetraacetic acid 
(EDTA), pelleted by low-speed centrifugation, and extracted with 300 pl pH 9.0 
extraction buffer (80 mM NaCl, 20 mM EDTA, 1 mM DTT, 20 mM TRIS-HCI, 
pH 9.0) per 5 X lo6 cells [18]. All steps were performed at 4°C. All described buf- 
fers contained phenylmethylsulfonyl fluoride (PMSF, 0.3 mg/ml) or Trasylol (0.014 
mg/ml) . 
Production of Antisera 
Antiserum against the major capsid protein of SV40 was made by injecting 
purified sodium dodecyl sulfate (SDS)-denatured VP 1 into rabbits and mice. Goat 
antiserum directed against SV40 virions was purchased from Cappel Laboratories. 
Guinea pig anti-VP3 serum was kindly supplied by Dr. W. Deppert, University of 
Ulm. 
lmmunoprecipitation 
Cell extract (100 pl; 2 X lo6 cells) was incubated with 5-10 p1 of antiserum for 
4 hr at 4°C. Some 100 pl of 10% (vol/vol) protein A-Sepharose was then added and 
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incubated for an additional 4 hr. The immunocomplexes were centrifuged for 5 min 
at 12,OOOg, and washed three times with 0.5 ml tris buffered saline, pH 7.4, with the 
following concentrations of NP40: 0.1 % , 0.05 % ,0.005 % . The complexes were then 
resuspended in 75 pl electrophoresis buffer to elute precipitated antigens [20]. After 
heating at 100°C for 5 min the protein A-Sepharose was pelleted by centrifugation. 
SDS-Polyacrylamide Gel Electrophoresis 
Cell extracts, purified virions, or immunoprecipitates were subjected to electro- 
phoresis through polyacrylamide gels in the presence of NaDodS04 as described [2  1, 
221. After drying, gels were fluorographed [23] and exposed to presensitized Kodak 
X-Omat R films [24]. 
Peptide Mapping 
Labeled proteins were separated through preparative SDS-gels and visualized 
by autoradiography . The identified protein bands were excised and proteins were 
eluted by homogenization of the gel. The eluted proteins were mixed with a carrier 
protein (bovine y-globulin) , concentrated by trichloroacetic acid (TCA)-precipitation 
and oxidized with performic acid as described [25]. Oxidized proteins were suspended 
in 0.5 ml of 0.05 M NH4HC03. Some 30 pg L-l-tosylamide-2-phenylethyl chloro- 
methyl ketone-treated trypsin (1 pg trypsinll ml 0.05 M NH4HC03) was added and 
the samples were incubated for 5 hr at 37°C. Another 20 pg trypsin was added and 
incubation was continued for another 5 hr. NH4HC03 was removed by three cycles 
of lyophilization. Two-dimensional mapping was done by electrophoresis at pH 4.7 
in the first dimension and ascending chromatography at pH 5.2 in the second 1261. 
E3H]-labeled peptides were visualized by fluorography with 2-methyl-naphthalene. 
[35S]-labeled peptides were detected by autoradiography using preflashed films. 
Individual [35S]-labeled peptides identified by autoradiography were scraped 
from the cellulose thin-layer plates and eluted in 300 pl electrophoresis buffer. 
Lyophilized peptides were resuspended in 6 p1 of the same buffer and rerun. 
RESULTS 
The 74K Protein Is Synthesized Late After Infection 
In order to determine the onset of the synthesis of the 74K protein, SV40- 
infected CV-1 cells were labeled every 2 hr with [35S] methionine. After incubating 
for 2 hr the cells were extracted and aliquots were analyzed by acrylamide gel electro- 
phoresis. The time course shows that synthesis of VPl has already started 10 hr 
postinfection. After another 2-3 hr the 74K protein becomes detectable (Fig. 1). 
Synthesis of the 74K Protein Is Inhibited by Ara-C 
To see whether the synthesis of the 74K protein depends on the expression of 
the early or late region of the SV40 genome, viral DNA synthesis was inhibited by 
Ara-C. The presence of Ara-C from the beginning of infection drastically reduces the 
rate of late transcription [27, 281. SV40-infected and mock-infected CV-I cells were 
labeled with [35S] methionine from 32 to 44 hr postinfection and extracted as 
described above. The extracts were analyzed on acrylamide gels and the labeled 
proteins were detected by autoradiography. Figure 2 shows that the synthesis of the 
74K protein in infected cells is clearly suppressed by Ara-C. 
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Fig. 1. Time course of protein synthesis of SV40-infected CV-1 cells. Infected cells were labeled in 
intervals of 2 hr with [35S] methionine (400 pCi/S X lo6 cells). Extraction was done as described in 
Materials and Methods. Proteins labeled from 0 to 2 hr postinfection correspond to the first fraction 
(left), proteins labeled from 46 to 48 hr postinfection correspond to the last fraction (right). The gel was 
10% acrylamide. 
lmmunoprecipitation With Antisera Against VP1 and VP3 
Antibodies directed against SDS-purified capsid proteins VP 1 and VP3 were 
used to examine the immunological relationship of the 74K protein to the capsid 
proteins. Immunoprecipitation was carried out as described. Rabbit serum directed 
against denatured VP1 precipitated the capsid protein, the 74K protein, and an 83K 
protein from labeled extracts of infected cells (Fig. 2G). The proteins were not 
precipitated from control cells or from infected cells treated with Ara-C (Fig. 
2D,E,H,I). The 74K protein could also be immunoprecipitated from lysates of 
infected cells using guinea pig anti-VP3 serum (Fig. 3B). Neither the capsid proteins 
nor the 74K protein were identified in immunoprecipitates of SV40 transformed cells 
(data not shown). 
To exclude the possibility that defective viruses were present in our virus stocks 
that could generate the 74K protein we also infected CV-1 cells with independent- 
ly isolated plaque-purified SV40 stocks. The 74K protein was found in each case 
(Fig. 3D,F). 
The 74K Protein Is Not Found in SV40 Particles 
Although the structural components of SV40 have been described [29-321, it 
was interesting to see if the 74K protein would be found in isolated virus particles. 
Radioactive SV40 was purified by cesium chloride banding followed by zonal sepa- 
ration in sucrose gradients. After dialysis, the virus was disrupted in SDS, reduced 
with 0-mercaptoethanol or DTT and analyzed by gel electrophoresis. The 74K protein 
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Fig. 2. 1"Sl Methionine-labeled proteins of pH 9.0 extracts and immunoprecipitates from mock- 
infected and SV40-infected CV-1 cells labeled 32- 44 hr postinfection. Some of the cell cultures were 
treated with Ara-C. Imrnunoprecipita~ron was done with rabbit anti-VPI serum. The kamplcs were 
separated o n  a 10% polyacrylamlde gel. A. mock infected; B. infected: C. infected + Ara-C. D. mock- 
infected, normal serum; E. mock-infccted. anti-VP I serum: F. infected. normal serum: G ,  infected. 
anti-VPI serum; H, infected t Ara-C. normal serum; I. infected t Ara-C. anti-VPI serum. 
could not be demonstrated in these preparations. and is therefore apparently not a 
component of the virus (data not shown). 
Fingerprint Analysis of the 74K Protein and the Capsid Proteins 
To examine the structural relationship between the 74K protein and the capsid 
proteins we compared their peptide fingerprints. Labeled proteins were purified by 
immunoprecipitation with goat anti-SV40 serum. Details of the preparation of the 
proteins and peptide mapping have been described in Materials and Methods. 
Figure 4 shows that the 74K protein has methionine-containing tryptic peptides 
comigrating with those found in the maps of VPl. The tryptic peptides of VPI 
immunoprecipitated from infected cells and the peptides of VPI from virus particles 
were almost identical (Fig. 4A,B).  However, two additional peptides of the 74K 
protein comigrated with the peptides of VP3 (Fig. 4C,D). This finding was confirmed 
when the eluted peptides were mixed and rerun (Fig. 5A,B).  
To study the relationship between the 74K protein and the structural proteins in 
more detail, [3H] serine-labeled proteins were also analyzed by two-dimensional 
peptide mapping. Figure 6 shows the serine-containing tryptic peptides of the struc- 
tural proteins VPI, VP2, VP3, and the 74K protein. 
202:JCB Krippl, Dreiseikehann, and Werchau 
A B C D E F 
Fig. 3.  Immunoprecipitates of pH 9.0 extracts from CV-I cells infected with different SV40 wild-type 
stocks that have been grown at low multiplicity from single plaques. Cells were labeled with [3sS] 
methionine 40-43 hr postinfection. Immunoprecipitations were done with guinea pig anti-VP3 serum 
and mouse anti-VP1 serum. The samples were separated on a 15% polyacrylamide gel. A,B, infected 
with the SV40 stock used in all experiments described in this paper; A, normal serum; B, anti-VP3 
serum; C, D, infected with a SV40 stock given by G. Walter, University of Freiburg; C, normal serum; 
D, anti-VP1 serum; E, F, infected with a SV40 stock which was kindly supplied by G. Sauer, Deutsches 
Krebsforschungszentrum Heidelberg; E, normal serum; F, anti-VP1 serum. 
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Fig. 4. Tryptic peptide analysis of [35S] methionine-labeled VP1, VP3, and the 74K protein. The 
amount of radioactivity loaded onto each thin-layer plate and the exposure times are as foHows: A, VPI 
purified by immunoprecipitation, 70,000 cpm, 4 days; B, VP1 from purified SV40 particles, 64,000 
cpm, 3 days; C, 74K protein purified by immunoprecipitation, 60,OOO cpm, 4 days; D, VP3 from 
purified SV40 particles, 5,OOO cpm, 14 days. 
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Fig. 5. Rerun of comigration: methonine tryptic peptides of the 74K protein and VP3. Eluted pcptides 
to be analyzed were again separated by electrophoresis and chromatography. The eluted peptides are 
marked in Figure 4 by dots. A,  peptides of VP3, 700 cpm, 22 days; B, mixture of peptides of VP3 and 
peptides of the 74K protein, 400 cpm of each, 22 days. 
The 74K protein shares 13 serine-containing peptides with VP1; the common 
pcptides are indicated by arabic numerals (Fig. 6A,B). Six tryptic peptides of the 74K 
protein (a-f) are present in the digests of VP2 and VP3 (Fig. 6B-D). As expected, 
the peptide patterns of VP2 and VP3 are in part identical. The unique peptides of 
VP2 are indicated by arrows. However, three peptides identified in the maps of VP2 
and VP3 are not found in the digest of the 74K protein. The results have been 
confirmed by mixing equal amounts of the digests and fractionating the mixtures in 
the same way (data not shown). ‘Taken together these data indicate that the 74K 
protein is constructed of VP1 and part of VP3. 
DISCUSSION 
The investigations reported in this paper show that the newly identified 74K 
protein observed in SV40-infected monkey cells is synthesized after the onset of viral 
DNA replication. This is based on ( 1 )  the finding that the 74K protein was first 
detectable 12-13 hr postinfection, and (2) the fact that its synthesis was inhibited in 
the presence of Ara-C, as was the synthesis of the capsid protein. Traces of a 74K 
protein are present already 2 hr after infection. This protein has been shown to be of 
cellular origin. It  migrates slightly faster in 7.5% acrylamide gels than the viral 74K 
protein and its synthesis can be stimulated by SV40 and by fetal calf serum [33]. It 
therefore may well be related to the virus- and heat-shock-inducible 72K cellular 
protein described by Khandjian and Tiirler [34]. 
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Fig. 6. t3H] serine fingerprints of VPl,  VP2, VP3, and the 74K protein. Purification, digestion, and 
fingerprinting were done as before. The cornigrating peptides of VPl and the 74K protein are indicated 
by numbers; small letters mark the comigrating peptides of VP2, VP3, and the 74K protein. Arrows 
indicate the position of the peptides unique to VP2. A, VPl purified by irnrnunoprecipitation, 30,000 
cpm, 17 days; B, 74K protein purified by irnrnunoprecipitation, 6,000 cpm, 8 wk; C, VP3 purified by 
immunoprecipitation, 30,000 cprn, 17 days; D, VP2 purified by imrnunoprecipitation, 5,400 cpm, 8 wk. 
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It could be argued that the 74K protein is made by defective viruses present in 
our virus stock. However, since this protein was found with different virus stocks and 
plaque isolates, at about the same concentration in each case, we consider this 
possibility to be unlikely. In contrast, the 74K protein was not found in SV40- 
transformed cells. 
Our immunoprecipitation data revealed that the 74K protein can be precipitated 
using monospecific sera directed against the capsid proteins VP1 and VP3. It is rea- 
sonable to assume that the 74K protein is specifically recognized by these antibodies 
because the structural relationship to the capsid protein could be demonstrated by pep- 
tide mapping. These results, however, do not exclude the possibility that the 74K pro- 
tein was coprecipitated with the capsid protein, as was VP3 with VP1 (Fig. 3D,F). The 
83K protein, which is also precipitated by anti-VP1, is presently being investigated. 
The viral nature of the 74K protein was demonstrated by tryptic peptide analysis 
of the structural proteins and the 74K protein. We found that the 74K protein shares 
all the methionine-containing peptides with VP1 and two methionine peptides with 
VP3. This structural relationship was confirmed by comparison of the [3H] serine- 
labeled peptides of the 74K protein and those of the capsid proteins. The 74K protein 
contains 13 serine peptides comigrating with those of VP1; six serine peptides found 
in the digests of VP2 and VP3 were also identified in the tryptic pattern of the 74K 
protein. The peptides unique to VP2 were not present in the map of the 74K protein. 
Moreover, three serine peptides contained in VP2 and VP3 were clearly absent in the 
tryptic digest of the 74K protein. In view of the two-dimensional mobilities of these 
three serine peptides we believe that they are derived from the COOH-terminus of 
VP3. The results indicate that the 74K protein contains the amino acid sequence of 
VP1 and part of the N-terminal sequence of VP3. 
The possibility that the 74K protein is posttranslationally constructed of VP 1 
and a shortened VP3 is very unlikely for the following reasons: VP3 does not contain 
cysteine to form an interchain-S-S-linkage with VP1 and noncovalent interactions 
between the two proteins can almost be excluded because denaturation with 3 % SDS, 
8 M urea, or 6 M guanidine hydrochloride yields unchanged amounts of the 74K 
protein. 
We therefore consider that the 74K protein is translated from an individual 
mRNA molecule. This mRNA should be transcribed from the entire late region of 
SV40 and be spliced in the overlapping region of VPl and VP3, so that the RNA can 
be translated in both reading frames. A similar model was considered for the Pr 
180gag-F’’ protein of RSV [35].The mRNA coding for the 74K protein remains to be 
identified and characterized to verify the proposed model. The fact that the in vitro 
translation experiments of Hunter [12] show no 74K protein does not argue against 
the existence of such a mRNA, because the 74K protein is made in smaller amounts 
than VPl and VP3 and therefore its mRNA may not have been found. 
The functions of the described protein are not known at present. However, the 
74K protein may be involved in virus assembly, although it is not a part of the virus, 
and could represent some kind of a scaffolding protein, as has been proposed for late 
adenovirus proteins that are absent from mature virions [36,37]. 
ACKNOWLEDGMENTS 
This investigation was supported by a grant from the Ministerium fiir Wissen- 
schaft und Forschung des Landes Nordrhein-Westfalen. 







































Tmze J: “DNA Tumor Viruses, Molecular Biology of DNA Tumor Viruses, Part 2.” Cold Spring 
Harbor, NY: Cold Spring Harbor Laboratories, 1980. 
Celma ML, Dhar R, Pan J, Weissman SM: Nucleic Res 4:2549, 1977. 
Ghosh PK, Reddy VB, Swinscol J, Chondary P, Lebowitz P, Weissman SM: Biol Chem 253:3643, 
1978. 
Haegeman G, Fiers W: Nature 273:70, 1978. 
Haegeman G, Fiers W: Nucleic Acids Res 5:2359, 1978. 
Hsu M, Ford J: Proc Natl Acad Sci USA 74:4982, 1977. 
Lai C-J, Dhar R, Khoury G: Cell 14:971, 1978. 
Prives CL, Shure H: J Virol 29: 1254, 1979. 
Ghosh PK, Reddy VB, Swinscol J, Lebowitz P, Weissman SM: J Mol Biol 126:813, 1978. 
Villarreal LP, White RT, Berg P: J Virol29:209, 1979. 
Wright PJ, Di Mayorca G: J Virol 15:825, 1975. 
Hunter T: Virology 95:511, 1979. 
Rozenblatt S, Mulligan RC, Gerecki M, Roberts BE, Rich A: Proc Natl Acad Sci USA 73:2747, 
1976. 
Cole CN, Landers T, Goff SP, Manteuil-Bmtlag S, Berg P: J Virol 24:277, 1977. 
Youngner JS: Proc SOC Exp Biol 85:202, 1975. 
Biittner W, Werchau H: Virology 52:553, 1973. 
Pagano JS, Hutchinson CA: Methods Virol5:79, 1971. 
Carroll RB, Smith AE: Proc Natl Acad Sci USA 73:2254, 1976. 
Walter G,  Roblin R, Dulbecco R: Proc Natl Acad Sci USA 69:921, 1972. 
Schwyzer M: INSERM 69:63, 1978. 
Laemmli UK: Nature 227:680, 1970. 
Maize1 JV Jr: In Maramorosch K, Koprowski, H (eds): “Methods in Virology,” Vol. 15. New 
York: Academic Press, 1971, p 179. 
Bonner WM, Laskey RA: Eur J Biochem 46:83, 1974. 
Laskey RA, Mills AD: Eur J Biochem 56:335, 1975. 
Wheeler T, Bayley ST, Harvey R, Crawford LV, Smith AE: J Virol 21:215, 1977. 
Beemon K, Hunter T: J Virol 28:551, 1978. 
Del Villano BC, Defendi V: Virology 51:34, 1973. 
Tonegawa S, Walter G,  BernardiniA, Dulbecco R: Cold Spring Harbor Symp Quant Biol 35:823, 
1971. 
Girard M, Marty L, Suarez F: Biochem Biophys Res Commun 40:97, 1970. 
Hirt B, Gesteland RF: Lepetit College Biol Med 2:98, 1971. 
Christiansen GT, Landers T, Griffith J, Berg B: J Virol 21: 1079, 1977. 
Miiller U, Zentgraf H, Eicken J, Keller W: Science 201:406, 1978. 
Patschinsky T, Leveringhaus M, Mehnert F, Werchau H: Hoppe-Seylers Z Physiol Chem 356:260, 
1975. 
Khandjian EW, Tiirler H: Mol Cell Biol 3: I ,  1983. 
Weiss SR, Hackett PB, Oppermann H, Ulrich A, Levintow L, Bishop JM: Cell 15:607, 1978 
Evardsson B, Everitt E, Jornvall H, Prage L, Philipson L: J Virol 19533, 1976. 
Winberg G, Wadell C :  J Virol 22:389, 1977. 
